688136 Kexing Biopharm
- 15.62
- -0.46-2.86%
Kexing Biopharm News
Announcement on the Opening of Special Account for Fund-raising and Signing of Tripartite Custody Agreement for Special Account for Fund-raising Storage
Announcement regarding payment of outstanding taxes.
Announcement on the Cancellation of Settlement Accounts for Some Raised Capital Wealth Management Products
Announcement on voluntary disclosure of the completion of the first subject enrollment in the phase I clinical trial for GB08 injection.
Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Legal opinion from JiaYuan Law Firm, Peking regarding the second interim shareholder meeting in 2024 of Sinovac Biotech Co., Ltd.
Announcement of the resolution of the 15th meeting of the second board of supervisors.
Announcement on Granting Restricted Stocks to Incentive Object
Legal Opinion of Jia Yuan Law Firm of Peking regarding Matters Relating to the Grant of Restricted Stock Incentive Plan of Sinovac Biotech Co., Ltd. in 2024.
List of restricted stock incentive plan recipients (Grant Date) for 2024.
Supervisory Board's verification opinion on the list of incentive recipients for the 2024 restricted stock incentive plan (as of the grant date)
Independent financial advisor report on the granting of restricted stock incentives by Sinovac Biotech Co., Ltd. in 2024 as provided by Shanghai Rongzheng Enterprise Consulting (Group) Co., Ltd.
Announcement of the Resolution of the 16th Meeting of the Second Board of Directors.
Self-check report on the trading of company stocks by insiders of the 2024 restricted stock incentive plan.
Announcement regarding the achievement of the performance condition for the first attribution period of the restricted stock incentive plan for the company in 2022, and the reserved grant for the second attribution period.
The Supervisory Board's review opinion on the verification of the list of incentive objects who meet the attribution conditions for the first grant period of the 2022 Restricted Stock Incentive Plan and the reserve grant of the second attribution period.
Legal Opinion from Jiayuan Law Firm, Peking, regarding Sinovac Biotech Limited's 2022 Restricted Stock Incentive Plan - First Grant of the Second Vesting Period and Achievement of Vesting Conditions and Invalidation of Part of the Restricted Stock.
Announcement on Invalidating Part of the Restricted Stock Incentive Plan for 2022
Explanation and verification opinions of the announcement of the list of restricted stocks incentive plan beneficiaries for the company's 2024 supervisory board.
2024 Second Interim Shareholder Meeting Documentation
Analysis
Price Target
No Data
